ACSL1 and metabolic dysfunction-associated steatohepatitis: Expression of genes involved in oxidation of fatty acids such as long-chain acyl-CoA synthetase (ACSL1) or acetyl-CoA acyltransferase (ACAA2) were neither downregulated in NASH livers, nor did MSC treatment affect expression.